Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

501 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab.
Meoni G, Ghini V, Maggi L, Vignoli A, Mazzoni A, Salvati L, Capone M, Vanni A, Tenori L, Fontanari P, Lavorini F, Peris A, Bartoloni A, Liotta F, Cosmi L, Luchinat C, Annunziato F, Turano P. Meoni G, et al. Among authors: bartoloni a. PLoS Pathog. 2021 Feb 1;17(2):e1009243. doi: 10.1371/journal.ppat.1009243. eCollection 2021 Feb. PLoS Pathog. 2021. PMID: 33524041 Free PMC article.
Therapeutic Efficacy of Autologous Non-Mobilized Enriched Circulating Endothelial Progenitors in Patients With Critical Limb Ischemia　- The SCELTA Trial.
Liotta F, Annunziato F, Castellani S, Boddi M, Alterini B, Castellini G, Mazzanti B, Cosmi L, Acquafresca M, Bartalesi F, Dilaghi B, Dorigo W, Graziani G, Bartolozzi B, Bellandi G, Carli G, Bartoloni A, Fargion A, Fassio F, Fontanari P, Landini G, Lucente EAM, Michelagnoli S, Orsi Battaglini C, Panigada G, Pigozzi C, Querci V, Santarlasci V, Parronchi P, Troisi N, Baggiore C, Romagnani P, Mannucci E, Saccardi R, Pratesi C, Gensini G, Romagnani S, Maggi E. Liotta F, et al. Among authors: bartoloni a. Circ J. 2018 May 25;82(6):1688-1698. doi: 10.1253/circj.CJ-17-0720. Epub 2018 Mar 23. Circ J. 2018. PMID: 29576595 Free article. Clinical Trial.
Early experience of an infectious and tropical diseases unit during the coronavirus disease (COVID-19) pandemic, Florence, Italy, February to March 2020.
Lagi F, Piccica M, Graziani L, Vellere I, Botta A, Tilli M, Ottino L, Borchi B, Pozzi M, Bartalesi F, Mencarini J, Spinicci M, Zammarchi L, Pieralli F, Zagli G, Nozzoli C, Romagnoli S, Bartoloni A; COCORA working group; COCORA working group members not listed as individual author. Lagi F, et al. Among authors: bartoloni a. Euro Surveill. 2020 Apr;25(17):2000556. doi: 10.2807/1560-7917.ES.2020.25.17.2000556. Euro Surveill. 2020. PMID: 32372754 Free PMC article.
Sars-CoV-2 Induced Coagulopathy and Prognosis in Hospitalized Patients: A Snapshot from Italy.
Giusti B, Gori AM, Alessi M, Rogolino A, Lotti E, Poli D, Sticchi E, Bartoloni A, Morettini A, Nozzoli C, Peris A, Pieralli F, Poggesi L, Marchionni N, Marcucci R. Giusti B, et al. Among authors: bartoloni a. Thromb Haemost. 2020 Aug;120(8):1233-1236. doi: 10.1055/s-0040-1712918. Epub 2020 May 26. Thromb Haemost. 2020. PMID: 32455440 No abstract available.
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent.
Mazzoni A, Salvati L, Maggi L, Capone M, Vanni A, Spinicci M, Mencarini J, Caporale R, Peruzzi B, Antonelli A, Trotta M, Zammarchi L, Ciani L, Gori L, Lazzeri C, Matucci A, Vultaggio A, Rossi O, Almerigogna F, Parronchi P, Fontanari P, Lavorini F, Peris A, Rossolini GM, Bartoloni A, Romagnani S, Liotta F, Annunziato F, Cosmi L. Mazzoni A, et al. Among authors: bartoloni a. J Clin Invest. 2020 Sep 1;130(9):4694-4703. doi: 10.1172/JCI138554. J Clin Invest. 2020. PMID: 32463803 Free PMC article.
Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study.
Vultaggio A, Vivarelli E, Virgili G, Lucenteforte E, Bartoloni A, Nozzoli C, Morettini A, Berni A, Malandrino D, Rossi O, Nencini F, Pieralli F, Peris A, Lagi F, Scocchera G, Spinicci M, Trotta M, Mazzetti M, Parronchi P, Cosmi L, Liotta F, Fontanari P, Mazzoni A, Salvati L, Maggi E, Annunziato F, Almerigogna F, Matucci A. Vultaggio A, et al. Among authors: bartoloni a. J Allergy Clin Immunol Pract. 2020 Sep;8(8):2575-2581.e2. doi: 10.1016/j.jaip.2020.06.013. Epub 2020 Jun 19. J Allergy Clin Immunol Pract. 2020. PMID: 32565226 Free PMC article.
Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study.
Vannucchi AM, Sordi B, Morettini A, Nozzoli C, Poggesi L, Pieralli F, Bartoloni A, Atanasio A, Miselli F, Paoli C, Loscocco GG, Fanelli A, Para O, Berni A, Tassinari I, Zammarchi L, Maggi L, Mazzoni A, Scotti V, Falchetti G, Malandrino D, Luise F, Millotti G, Bencini S, Capone M, Piccinni MP, Annunziato F, Guglielmelli P; RUXO-COVID Study Group. Vannucchi AM, et al. Among authors: bartoloni a. Leukemia. 2021 Apr;35(4):1121-1133. doi: 10.1038/s41375-020-01018-y. Epub 2020 Aug 19. Leukemia. 2021. PMID: 32814839 Free PMC article. Clinical Trial.
Quantitative and qualitative alterations of circulating myeloid cells and plasmacytoid DC in SARS-CoV-2 infection.
Peruzzi B, Bencini S, Capone M, Mazzoni A, Maggi L, Salvati L, Vanni A, Orazzini C, Nozzoli C, Morettini A, Poggesi L, Pieralli F, Peris A, Bartoloni A, Vannucchi AM, Liotta F, Caporale R, Cosmi L, Annunziato F. Peruzzi B, et al. Among authors: bartoloni a. Immunology. 2020 Dec;161(4):345-353. doi: 10.1111/imm.13254. Epub 2020 Oct 6. Immunology. 2020. PMID: 32870529 Free PMC article.
Clinical risk score to predict in-hospital mortality in COVID-19 patients: a retrospective cohort study.
Fumagalli C, Rozzini R, Vannini M, Coccia F, Cesaroni G, Mazzeo F, Cola M, Bartoloni A, Fontanari P, Lavorini F, Marcucci R, Morettini A, Nozzoli C, Peris A, Pieralli F, Pini R, Poggesi L, Ungar A, Fumagalli S, Marchionni N. Fumagalli C, et al. Among authors: bartoloni a. BMJ Open. 2020 Sep 25;10(9):e040729. doi: 10.1136/bmjopen-2020-040729. BMJ Open. 2020. PMID: 32978207 Free PMC article.
Cell-mediated and humoral adaptive immune responses to SARS-CoV-2 are lower in asymptomatic than symptomatic COVID-19 patients.
Mazzoni A, Maggi L, Capone M, Spinicci M, Salvati L, Colao MG, Vanni A, Kiros ST, Mencarini J, Zammarchi L, Mantengoli E, Menicacci L, Caldini E, Romagnani S, Liotta F, Morettini A, Rossolini GM, Bartoloni A, Cosmi L, Annunziato F. Mazzoni A, et al. Among authors: bartoloni a. Eur J Immunol. 2020 Dec;50(12):2013-2024. doi: 10.1002/eji.202048915. Epub 2020 Nov 9. Eur J Immunol. 2020. PMID: 33080068 Free article. Clinical Trial.
501 results